Cytosorbents
CTSO • NASDAQ
Cytosorbents is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Phillip Chan, with a market cap of $37.2M.
CEOPhillip Chan
Next Earnings
Upcoming earnings announcement for Cytosorbents
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.05
Revenue Estimate
$9.5M
Earnings History
Past 12 earnings reports for Cytosorbents
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.07Est: -$0.05 | -40.0% | $9.2MEst: $9.2M | +0.3% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.04Est: -$0.05 | +20.0% | $9.5MEst: $9.9M | -4.6% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.05Est: -$0.06 | +16.7% | $9.6MEst: $9.1M | +5.2% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.06Est: -$0.08 | +25.0% | $8.7MEst: $8.1M | +7.7% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.14Est: -$0.07 | -100.0% | $9.2MEst: $9.8M | -6.4% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.04Est: -$0.06 | +33.3% | $9.4MEst: $10.2M | -7.8% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.08Est: -$0.09 | +11.1% | $9.9MEst: $9.7M | +1.7% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.12Est: -$0.12 | 0.0% | $9.8MEst: $9.8M | +0.1% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.12Est: -$0.14 | +14.3% | $8.7MEst: $9.3M | -6.3% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.21Est: -$0.12 | -75.0% | $8.8MEst: $9.5M | -7.2% | — |
| Aug 1, 2023 | Q2 2023 | -$0.14Est: -$0.11 | -27.3% | $9.4MEst: $11.0M | -14.6% | 10-Q |
| May 2, 2023 | Q1 2023 | -$0.17Est: -$0.13 | -30.8% | $9.4MEst: $8.7M | +8.2% | — |